245 related articles for article (PubMed ID: 23053181)
1. Multiple angiogenetic factors are upregulated in POEMS syndrome.
Yamada Y; Sawai S; Misawa S; Kanai K; Shibuya K; Mori M; Moriya J; Sogawa K; Yamamoto H; Beppu M; Taniguchi J; Nakaseko C; Nomura F; Kuwabara S
Ann Hematol; 2013 Jan; 92(2):245-8. PubMed ID: 23053181
[TBL] [Abstract][Full Text] [Related]
2. [Crow-Fukase (POEMS) syndrome: pathophysiology and treatments].
Kuwabara S
Nihon Rinsho; 2013 May; 71(5):865-9. PubMed ID: 23777096
[TBL] [Abstract][Full Text] [Related]
3. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome.
Kanai K; Sawai S; Sogawa K; Mori M; Misawa S; Shibuya K; Isose S; Fujimaki Y; Noto Y; Sekiguchi Y; Nasu S; Nakaseko C; Takano S; Yoshitomi H; Miyazaki M; Nomura F; Kuwabara S
Neurology; 2012 Aug; 79(6):575-82. PubMed ID: 22843279
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
[TBL] [Abstract][Full Text] [Related]
5. Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome.
Sekiguchi Y; Misawa S; Shibuya K; Nasu S; Mitsuma S; Iwai Y; Beppu M; Sawai S; Ito S; Hirano S; Nakaseko C; Kuwabara S
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1346-8. PubMed ID: 23463868
[TBL] [Abstract][Full Text] [Related]
6. Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.
Kastritis E; Terpos E; Anagnostopoulos A; Xilouri I; Dimopoulos MA
Clin Lymphoma Myeloma; 2006 Jul; 7(1):73-6. PubMed ID: 16879774
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide in POEMS syndrome: case report.
Sinisalo M; Hietaharju A; Sauranen J; Wirta O
Am J Hematol; 2004 May; 76(1):66-8. PubMed ID: 15114600
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
Misawa S; Sato Y; Katayama K; Nagashima K; Aoyagi R; Sekiguchi Y; Sobue G; Koike H; Yabe I; Sasaki H; Watanabe O; Takashima H; Nishizawa M; Kawachi I; Kusunoki S; Mitsui Y; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
Lancet Neurol; 2016 Oct; 15(11):1129-37. PubMed ID: 27496680
[TBL] [Abstract][Full Text] [Related]
9. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome.
Kanai K; Kuwabara S; Misawa S; Hattori T
Intern Med; 2007; 46(6):311-3. PubMed ID: 17380000
[TBL] [Abstract][Full Text] [Related]
10. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease.
Wang X; Ye S; Xiong C; Gao J; Xiao C; Xing X
Jpn J Clin Oncol; 2011 Oct; 41(10):1221-4. PubMed ID: 21890654
[TBL] [Abstract][Full Text] [Related]
13. Autologous peripheral blood stem cell transplantation for POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Kikkawa Y; Nishimura M; Nakaseko C; Cho RK; Hattori T
Neurology; 2006 Jan; 66(1):105-7. PubMed ID: 16401856
[TBL] [Abstract][Full Text] [Related]
14. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome.
Yokouchi H; Baba T; Misawa S; Oshitari T; Kuwabara S; Yamamoto S
Br J Ophthalmol; 2020 Jan; 104(1):33-38. PubMed ID: 30914422
[TBL] [Abstract][Full Text] [Related]
15. [Treatment strategy for POEMS syndrome].
Kawamura N; Kira J
Brain Nerve; 2008 Jun; 60(6):621-6. PubMed ID: 18567357
[TBL] [Abstract][Full Text] [Related]
16. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
Kamezaki K; Nagafuji K
Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
[TBL] [Abstract][Full Text] [Related]
17. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
[TBL] [Abstract][Full Text] [Related]
18. [New strategy of treatment for POEMS syndrome--autologous peripheral blood stem cell transplantation and thalidomide therapy].
Kuwabara S
Brain Nerve; 2008 Jun; 60(6):627-33. PubMed ID: 18567358
[TBL] [Abstract][Full Text] [Related]
19. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
[TBL] [Abstract][Full Text] [Related]
20. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome.
Soubrier M; Sauron C; Souweine B; Larroche C; Wechsler B; Guillevin L; Piette JC; Rousset H; Deteix P
Am J Kidney Dis; 1999 Oct; 34(4):633-8. PubMed ID: 10516342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
